These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33517891)

  • 1. Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease.
    Zhang Y; Wang Y; Shi C; Shen M; Lu F
    Transl Neurodegener; 2021 Feb; 10(1):6. PubMed ID: 33517891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal microvascular attenuation in mental cognitive impairment and Alzheimer's disease by optical coherence tomography angiography.
    Wu J; Zhang X; Azhati G; Li T; Xu G; Liu F
    Acta Ophthalmol; 2020 Sep; 98(6):e781-e787. PubMed ID: 32153141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis.
    Czakó C; Kovács T; Ungvari Z; Csiszar A; Yabluchanskiy A; Conley S; Csipo T; Lipecz A; Horváth H; Sándor GL; István L; Logan T; Nagy ZZ; Kovács I
    Geroscience; 2020 Dec; 42(6):1499-1525. PubMed ID: 33011937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L
    J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal imaging in Alzheimer's disease.
    Cheung CY; Mok V; Foster PJ; Trucco E; Chen C; Wong TY
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):983-994. PubMed ID: 34108266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Neurodegeneration Measured With Optical Coherence Tomography and Neuroimaging in Alzheimer Disease: A Systematic Review.
    Carazo-Barrios L; Cabrera-Maestre A; Alba-Linero C; Gutiérrez-Bedmar M; Garzón-Maldonado FJ; Serrano V; de la Cruz-Cosme C; García-Casares N
    J Neuroophthalmol; 2023 Mar; 43(1):116-125. PubMed ID: 36255105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-Retina Might Reflect Alzheimer's Disease Stage.
    Santangelo R; Huang SC; Bernasconi MP; Falautano M; Comi G; Magnani G; Leocani L
    J Alzheimers Dis; 2020; 77(4):1455-1468. PubMed ID: 32925026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Ge YJ; Xu W; Ou YN; Qu Y; Ma YH; Huang YY; Shen XN; Chen SD; Tan L; Zhao QH; Yu JT
    Ageing Res Rev; 2021 Aug; 69():101361. PubMed ID: 34000463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How far reaches earliness of optical coherence tomography in cognitive impairment].
    Gimenez-Castejon D; Gomez-Gallego M; Martinez-Martinez ML; Dudekova M; Lajara-Blesa J
    Rev Neurol; 2016 Jul; 63(1):5-10. PubMed ID: 27345274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances.
    Gupta VB; Chitranshi N; den Haan J; Mirzaei M; You Y; Lim JK; Basavarajappa D; Godinez A; Di Angelantonio S; Sachdev P; Salekdeh GH; Bouwman F; Graham S; Gupta V
    Prog Retin Eye Res; 2021 May; 82():100899. PubMed ID: 32890742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perspectives of the diagnosis of Alzheimer's disease using optic coherent tomography].
    Bogolepova AN; Zhuravleva AN; Makhnovich EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):112-117. PubMed ID: 29053131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
    Hui J; Zhao Y; Yu S; Liu J; Chiu K; Wang Y
    PLoS One; 2021; 16(8):e0255362. PubMed ID: 34379663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease.
    Ikram MK; Cheung CY; Wong TY; Chen CP
    J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):917-22. PubMed ID: 22733082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a dual-stream attention neural network to characterize mild cognitive impairment based on retinal images.
    Gao H; Zhao S; Zheng G; Wang X; Zhao R; Pan Z; Li H; Lu F; Shen M
    Comput Biol Med; 2023 Nov; 166():107411. PubMed ID: 37738896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Shao Y; Jiang H; Wei Y; Shi Y; Shi C; Wright CB; Sun X; Vanner EA; Rodriguez AD; Lam BL; Rundek T; Baumel BS; Gameiro GR; Dong C; Wang J
    J Alzheimers Dis; 2018; 64(4):1261-1273. PubMed ID: 30040712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease.
    More SS; Beach JM; McClelland C; Mokhtarzadeh A; Vince R
    ACS Chem Neurosci; 2019 Nov; 10(11):4492-4501. PubMed ID: 31603648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglion Cell Layer Thinning in Alzheimer's Disease.
    López-de-Eguileta A; Cerveró A; Ruiz de Sabando A; Sánchez-Juan P; Casado A
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33096909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease pathophysiology in the Retina.
    Gaire BP; Koronyo Y; Fuchs DT; Shi H; Rentsendorj A; Danziger R; Vit JP; Mirzaei N; Doustar J; Sheyn J; Hampel H; Vergallo A; Davis MR; Jallow O; Baldacci F; Verdooner SR; Barron E; Mirzaei M; Gupta VK; Graham SL; Tayebi M; Carare RO; Sadun AA; Miller CA; Dumitrascu OM; Lahiri S; Gao L; Black KL; Koronyo-Hamaoui M
    Prog Retin Eye Res; 2024 Jul; 101():101273. PubMed ID: 38759947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects.
    Chalkias E; Topouzis F; Tegos T; Tsolaki M
    J Alzheimers Dis; 2021; 80(2):493-504. PubMed ID: 33554918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography-angiography.
    Biscetti L; Lupidi M; Luchetti E; Eusebi P; Gujar R; Vergaro A; Cagini C; Parnetti L
    Eur J Neurol; 2021 Jul; 28(7):2185-2191. PubMed ID: 33852770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.